• BridgeBio Pharma (NASDAQ:BBIO) Earns "Overweight" Rating from Cantor Fitzgerald

    来源: Buzz FX / 22 2月 2025 12:56:17   America/Chicago


    BridgeBio Pharma (NASDAQ:BBIO) Earns "Overweight" Rating from Cantor Fitzgerald Written by MarketBeat February 22, 2025 Share Link copied to clipboard. BridgeBio Pharma ( NASDAQ:BBIO - Get Free Report ) 's stock had its "overweight" rating
    Read more...
分享